Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwok-Chiu Chang

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 7, 2009
Standardized regimens and the emergence of multidrug-resistant tuberculosisKwok Chiu Chang
The Lancet. Respiratory Medicine|May 15, 2026
endTB-Q trial: a caveat on confounding by baseline drug resistanceKwok Chiu Chang
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosisKwok-Chiu Chang, Keertan Dheda
Respirology (Carlton, Vic.)|December 7, 2018
Management of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmesWing Wai Yew, Kwok Chiu Chang
American Journal of Respiratory and Critical Care Medicine|May 17, 2012
Lung cancer is more common in early GOLD stages of COPD: a spurious association?Kwok Chiu Chang, Chi Chiu Leung
American Journal of Respiratory and Critical Care Medicine|May 7, 2020
ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?Kwok-Chiu Chang, Wing-Wai Yew
Lancet (London, England)|June 30, 2009
Moxifloxacin versus ethambutol in initial tuberculosis treatmentKwok Chiu Chang, Chi Chiu Leung
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Experimental models of tuberculosis: can we trust the mouse?Denis Anthony Mitchison, Kwok Chiu Chang
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debateKwok Chiu Chang, Chi Chiu Leung
The Lancet. Infectious Diseases|October 31, 2021
Adverse event reporting and Bell's palsy risk after COVID-19 vaccinationKwok-Chiu Chang, Fuk-Yip Kong
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory and Critical Care Medicine|March 7, 2009
Standardized regimens and the emergence of multidrug-resistant tuberculosisKwok Chiu Chang
The Lancet. Respiratory Medicine|May 15, 2026
endTB-Q trial: a caveat on confounding by baseline drug resistanceKwok Chiu Chang
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosisKwok-Chiu Chang, Keertan Dheda
Respirology (Carlton, Vic.)|December 7, 2018
Management of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmesWing Wai Yew, Kwok Chiu Chang
American Journal of Respiratory and Critical Care Medicine|May 17, 2012
Lung cancer is more common in early GOLD stages of COPD: a spurious association?Kwok Chiu Chang, Chi Chiu Leung
American Journal of Respiratory and Critical Care Medicine|May 7, 2020
ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?Kwok-Chiu Chang, Wing-Wai Yew
Lancet (London, England)|June 30, 2009
Moxifloxacin versus ethambutol in initial tuberculosis treatmentKwok Chiu Chang, Chi Chiu Leung
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Experimental models of tuberculosis: can we trust the mouse?Denis Anthony Mitchison, Kwok Chiu Chang
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debateKwok Chiu Chang, Chi Chiu Leung
The Lancet. Infectious Diseases|October 31, 2021
Adverse event reporting and Bell's palsy risk after COVID-19 vaccinationKwok-Chiu Chang, Fuk-Yip Kong
Pageof 7